Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies - Top-Institutions - MDSpire

Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies

  • By

  • Jingjie Gao

  • Yanan Pei

  • Lijuan Wei

  • Bo Yang

  • Hongtao Yang

  • June 11, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Nephrology

  • #2

    Columbia University Irving Medical Center / NewYork-Presbyterian
    Columbia University Irving Medical Center / NewYork-Presbyterian

    New York, New York

    Key Differentiators

    • Nephrology

Original Source(s)

Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies

  • by Jingjie Gao, Yanan Pei, Lijuan Wei, Bo Yang, Hongtao Yang

  • June 11, 2026

Related Content

Inhibitory impact of A1 and A2 cow’s milk on human peripheral blood mononuclear cells identifies TOM1 as a candidate anti-inflammatory mediator

Therapeutic scarification, shadow pain, and integrative geriatric rehabilitation for chronic musculoskeletal pain in older adults in Cameroon: a prospective mixed-methods observational study

Fibromyalgia in cancer patients: a systematic review and clinical implications for integrated care